Literature DB >> 8022790

Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.

M Kawamura1, D W McVicar, J A Johnston, T B Blake, Y Q Chen, B K Lal, A R Lloyd, D J Kelvin, J E Staples, J R Ortaldo.   

Abstract

Protein-tyrosine kinases (PTKs) are critical enzymes for receptor-mediated signaling in lymphocytes. Because natural killer (NK) cells are large granular lymphocytes with specialized effector function, we set out to identify PTKs preferentially expressed in these cells. One such PTK was identified and molecularly cloned. The predicted amino acid sequence shows that this kinase lacks SH2 or SH3 domains typical of src family kinases but has tandem nonidentical catalytic domains, indicating that it is a member of the Janus family of PTKs. Immunoprecipitation using antiserum generated against a peptide corresponding to the deduced amino acid sequence of this gene revealed a kinase with a molecular weight of approximately 125,000. The pattern of expression of this kinase contrasted sharply with that of other Janus kinases, which are ubiquitously expressed. The kinase described in the present study was found to be more limited in its expression; expression was found in NK cells and an NK-like cell line but not in resting T cells or in other tissues. In contrast, stimulated and transformed T cells expressed the gene, suggesting a role in lymphoid activation. Because of its homology and tissue expression, we have tentatively termed this PTK gene L-JAK for leukocyte Janus kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022790      PMCID: PMC44204          DOI: 10.1073/pnas.91.14.6374

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  tyk2, prototype of a novel class of non-receptor tyrosine kinase genes.

Authors:  I Firmbach-Kraft; M Byers; T Shows; R Dalla-Favera; J J Krolewski
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

Review 2.  Biology and clinical relevance of human natural killer cells.

Authors:  M J Robertson; J Ritz
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

3.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor.

Authors:  L E Samelson; A F Phillips; E T Luong; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.

Authors:  A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing.

Authors:  E Vivier; P Morin; C O'Brien; B Druker; S F Schlossman; P Anderson
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

6.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

7.  Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.

Authors:  N Kobayashi; T Kono; M Hatakeyama; Y Minami; T Miyazaki; R M Perlmutter; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Interferon-induced nuclear signalling by Jak protein tyrosine kinases.

Authors:  O Silvennoinen; J N Ihle; J Schlessinger; D E Levy
Journal:  Nature       Date:  1993-12-09       Impact factor: 49.962

9.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

View more
  80 in total

Review 1.  Targeting the Jak/STAT pathway for immunosuppression.

Authors:  J J O'shea
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

Review 3.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog.

Authors:  Titus J Boggon; Yiqun Li; Paul W Manley; Michael J Eck
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

Review 5.  Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge Cortes; Srdan Verstovsek
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 6.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

7.  Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Authors:  Y J Zhou; K S Magnuson; T P Cheng; M Gadina; D M Frucht; J Galon; F Candotti; R L Geahlen; P S Changelian; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 8.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

9.  Interleukin 2 signaling involves the phosphorylation of Stat proteins.

Authors:  D A Frank; M J Robertson; A Bonni; J Ritz; M E Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 10.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.